Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 337
Immune Disorders Drugs 206
Biopharmaceuticals 176
Musculoskeletal Disorders Drugs 127
Genomics 115
Cardiovascular Drugs 103
Biotechnology 84
Pharmaceuticals 80
Drug Discovery 76
Endocrine and Metabolic Disorders Drugs 75
Biosimilars and Biosuperiors 72
Allergy and Immunology 66
Infusions and Injectables 65
Leukemia Drugs 63
Hematological Drugs 60
Clinical Trials 54
Oncology 52
Dermatological Drugs 51
Central Nervous System Drugs 49
Women's Health 45
Liver and Kidney Disorders Drugs 45
Needles and Syringes 42
Drug Delivery 37
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 30
Infectious Diseases Drugs 28
Brain Cancer Drugs 27
Enzymes 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Proteomics 26
Gastrointestinal Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Lymphoma Drugs 23
Dermatology 19
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Optical 17
Therapeutic Area 16
Respiratory Drugs 16
Urology and Nephrology 15
Healthcare Services 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Gastroenterology 7
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Company Reports 5
Animal Pharmaceuticals 5
Neurology 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,083 Results (Page 48 of 105)
- Relevance
  Sort by

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

 Report
January 2019
230 Pages
Global

From

€3548EUR$3,999USD£3,072GBP

$Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025 - Product Thumbnail Image$

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025

 Clinical Trials
July 2025
450 Pages
Global

From

€4437EUR$5,000USD£3,841GBP

Translational Regenerative Medicine Market Report 2024-2034

 Report
February 2024
270 Pages
Global

From

€5201EUR$6,066USD£4,350GBP

Nanomedicine Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3984EUR$4,490USD£3,449GBP

Prostate Cancer Therapeutics Market

 Report
January 2024
200 Pages
Global

From

€3682EUR$4,150USD£3,188GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
589 Pages
Global

From

€2218EUR$2,500USD£1,920GBP

AI in Clinical Trials Market Industry Trends and Global Forecasts to 2035: By Trial Phase, Target Therapeutic Area, End-User and Key Geographical Regions

 Report
March 2025
304 Pages
Global

From

€4258EUR$4,799USD£3,686GBP

Regenerative Medicine Collaboration and Licensing Deals 2019-2025

 Report
November 2025
750 Pages
Global

From

€3545EUR$3,995USD£3,069GBP

Brain Tumor Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3984EUR$4,490USD£3,449GBP

Prostate Cancer- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2662EUR$3,000USD£2,304GBP

Glioblastoma Multiforme Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4215EUR$4,750USD£3,649GBP

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
210 Pages
Global

From

€1775EUR$2,000USD£1,536GBP

Colorectal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
172 Pages
Global

From

€3993EUR$4,500USD£3,457GBP

Cutaneous T-Cell-Lymphoma Market - Global Forecast 2025-2032

 Report
November 2025
195 Pages
Global

From

€3495EUR$3,939USD£3,026GBP

Radiation Toxicity Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€3993EUR$4,500USD£3,457GBP

Protein Expression Market 2024-2028

 Report
May 2024
168 Pages
Global

From

€2218EUR$2,500USD£1,920GBP

Protein Engineering Market 2026-2030

 Report
January 2026
294 Pages
Global

From

€2218EUR$2,500USD£1,920GBP

Adult Malignant Glioma Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3984EUR$4,490USD£3,449GBP

Glioblastoma Multiforme (GBM) Treatment Market Report 2025

 Report
March 2025
175 Pages
Global

From

€3984EUR$4,490USD£3,449GBP

Malignant Glioma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1775EUR$2,000USD£1,536GBP

2,083 Results (Page 48 of 105)
- 1
- 46
- 47
- 48
- 49
- 50

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.